Insider trading

Period: 12 months Stock: NTRA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

177 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

177 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

177 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

177 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
177 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
177 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

177 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
3 Feb 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$307.84K 1,334 at 230.77
0.6%
Planned (10b5-1)
3 Feb 2026
Sheena Jonathan Director
Sold on a plan
$100.38K 435 at 230.77
0.2%
Planned (10b5-1)
2 Feb 2026
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 6×
$19.68M 85,299 at 230.72
40.0%
Planned (10b5-1)
2 Feb 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 6×
$694.31K 3,000 at 231.44
2.1%
Planned (10b5-1)
29 Jan 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$430.16K 1,867 at 230.40
3.1%
Planned (10b5-1)
28 Jan 2026
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$866.99K 3,648 at 237.66
1.7%
Planned (10b5-1)
28 Jan 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$573.22K 2,413 at 237.56
3.8%
Planned (10b5-1)
28 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$285.19K 1,200 at 237.66
0.8%
Planned (10b5-1)
28 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$237.66K 1,000 at 237.66
0.4%
Planned (10b5-1)
28 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$220.55K 928 at 237.66
0.5%
Planned (10b5-1)
28 Jan 2026
Sheena Jonathan Director
Sold on a plan
$45.39K 191 at 237.66
0.1%
Planned (10b5-1)
27 Jan 2026
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$558.51K 2,322 at 240.53
1.1%
Planned (10b5-1)
27 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$243.66K 1,013 at 240.53
0.7%
Planned (10b5-1)
27 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$213.11K 886 at 240.53
0.4%
Planned (10b5-1)
27 Jan 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$188.58K 784 at 240.53
1.2%
Planned (10b5-1)
27 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$188.58K 784 at 240.53
0.4%
Planned (10b5-1)
27 Jan 2026
Sheena Jonathan Director
Sold on a plan
$69.99K 291 at 240.53
0.1%
Planned (10b5-1)
23 Jan 2026
Sheena Jonathan Director · indirect
Sold on a plan 7×
$365.91K 1,500 at 243.94
6.4%
Planned (10b5-1)
21 Jan 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan 2×
$9.02M 37,175 at 242.54
36.7%
Planned (10b5-1)
21 Jan 2026
Sheena Jonathan Director
Sold on a plan 3×
$741.61K 3,163 at 234.46
1.2%
Planned (10b5-1)
21 Jan 2026
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$373.65K 1,590 at 235.00
0.7%
Planned (10b5-1)
21 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$102.93K 438 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$79.67K 339 at 235.00
0.2%
Planned (10b5-1)
21 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$68.86K 293 at 235.00
0.2%
Planned (10b5-1)
20 Jan 2026
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan
$16.89M 71,932 at 234.74
24.9%
Planned (10b5-1)
20 Jan 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$5.62M 23,948 at 234.74
19.4%
Planned (10b5-1)
20 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$5.45M 23,205 at 234.74
13.8%
Planned (10b5-1)
20 Jan 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$4.51M 19,234 at 234.74
7.8%
Planned (10b5-1)
20 Jan 2026
Fesko John PRESIDENT, CHIEF BUS. OFFICER
Sold on a plan
$4.18M 17,806 at 234.74
9.1%
Planned (10b5-1)
20 Jan 2026
Sheena Jonathan Director
Sold on a plan
$699.76K 2,981 at 234.74
1.1%
Planned (10b5-1)
2 Jan 2026
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 2×
$881.48K 3,848 at 229.08
2.7%
Planned (10b5-1)
2 Jan 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 2×
$675.62K 2,951 at 228.95
2.3%
Planned (10b5-1)
19 Dec 2025
Sheena Jonathan Director · indirect
Sold on a plan 4×
$338.91K 1,500 at 225.94
6.2%
Planned (10b5-1)
17 Dec 2025
Sheena Jonathan Director
Sold on a plan 3×
$696.91K 3,070 at 227.01
1.4%
Planned (10b5-1)
12 Dec 2025
ROSENMAN HERM Director
Sold at will 4×
$11.01M 48,419 at 227.42
70.4%
Sold half or more
12 Dec 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold at will
$1.08M 4,692 at 230.76
4.0%
Not planned
5 Dec 2025
Chapman Rowan E Director
Sold at will 2×
$1.06M 4,366 at 243.10
43.0%
Not planned
1 Dec 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 3×
$1.05M 4,400 at 238.07
3.0%
Planned (10b5-1)
1 Dec 2025
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan 4×
$714.46K 3,000 at 238.15
2.7%
Planned (10b5-1)
24 Nov 2025
BOTHA ROELOF Director · indirect
Sold at will 11×
$17.71M 75,000 at 236.12
6.1%
Not planned
21 Nov 2025
Sheena Jonathan Director · indirect
Sold on a plan 2×
$920.03K 4,000 at 230.01
14.7%
Planned (10b5-1)
20 Nov 2025
Sheena Jonathan Director
Sold on a plan
$2.25M 10,000 at 225.08
4.3%
Planned (10b5-1)
20 Nov 2025
Baynes Roy D. Director
Sold on a plan 5×
$1.71M 7,668 at 223.08
29.5%
Planned (10b5-1)
19 Nov 2025
Baynes Roy D. Director
Sold on a plan 3×
$1.10M 5,112 at 215.00
21.8%
Planned (10b5-1)
11 Nov 2025
Sheena Jonathan Director · indirect
Sold on a plan 6×
$311.93K 1,500 at 207.96
5.6%
Planned (10b5-1)
7 Nov 2025
Sheena Jonathan Director
Sold on a plan 7×
$591.16K 3,070 at 192.56
1.3%
Planned (10b5-1)
4 Nov 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan 2×
$4.59M 22,900 at 200.51
1.0%
Planned (10b5-1)
3 Nov 2025
Chapman Steven Leonard CEO AND PRESIDENT
Sold on a plan 3×
$32.13M 160,703 at 199.96
52.6%
Sold half or more
3 Nov 2025
Rabinowitz Matthew EXECUTIVE CHAIRMAN
Sold on a plan
$3.42M 17,100 at 200.00
0.7%
Planned (10b5-1)
3 Nov 2025
Sheena Jonathan Director · indirect
Sold on a plan 2×
$800.27K 4,000 at 200.07
13.3%
Planned (10b5-1)
Showing 101–150 of 177. ← Newer Page 3 of 4 Older →